© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Citius Pharmaceuticals Completes Acquisition of Leonard-Meron Biosciences
Posted 5th April 2016

Citius Pharmaceuticals Completes Acquisition of Leonard-Meron Biosciences

Citius Pharmaceuticals, Inc.today announced completion of the acquisition of Leonard-Meron Biosciences, Inc.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Citius Pharmaceuticals Completes Acquisition of Leonard-Meron Biosciences
Image

Citius Pharmaceuticals, Inc. today announced completion of the acquisition of Leonard-Meron Biosciences, Inc. Pursuant to the acquisition, Citius acquired all of the outstanding shares of LMB common stock in exchange for shares of Citius common stock.

LMB is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. LMB’s leading drug candidate, Mino-Lok™, is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (“CRBSIs”).

Mino-Lok™ is a patent-protected, novel solution containing minocycline, edetate (disodium EDTA), and ethyl alcohol, which act to break down bacterial biofilm, eradicate the bacteria, provide anti-clotting properties to maintain patency, and salvage the indwelling central venous catheter (“CVC”). Mino-Lok™ is entering phase 3 trials after demonstrating safety in its phase 2b trial conducted at the MD Anderson Cancer Center in Houston. Recently, the U.S. Food and Drug Administration (“FDA”) granted a Qualified Infectious Disease Product (“QIDP”) designation for Mino-Lok™.  Receiving QIDP designation means that Mino-Lok™ is now eligible for Fast Track designation, Priority Review, and a five-year extension of market exclusivity.

Leonard Mazur, Chairman of the Board of Directors of Citius SAID:

“Management is excited with the acquisition which has provided us immediate access to Mino-Lok™, a phase 3 ready program in a billion-dollar industry. We are especially pleased with the expansion of our management team to include industry veteran, Mr. Myron Holubiak, who has assumed the position of our Chief Executive Officer and is now directing all of our business and development programs including our prescription haemorrhoid treatment.

“Mr. Holubiak has an extensive background in pharmaceutical general management, having been president of Roche Labs Inc., and also in a number of related disciplines including health economics, an increasingly important perspective in healthcare today. We are now prepared to seek additional opportunities to expand our product pipeline in critical care and associated treatment areas while conforming to our growth philosophy of developing and introducing drug products that address unmet medical needs and provide cost-effective solutions in today’s healthcare world.  We are at the forefront of an exciting time for Citius”.

Prior to the acquisition, Mr. Leonard Mazur was the Chief Executive Officer and Chairman of the Board of Directors of Citius and a principal stockholder of LMB; and, Mr. Myron Holubiak was the President and Chief Executive Officer of LMB, a significant stockholder of LMB, and a director of Citius.  Pursuant to the acquisition, Mr. Holubiak assumed the role of President and Chief Executive Officer of Citius and will continue as a director of Citius, and Mr. Mazur will remain as the Chairman of the Board of Citius.  All key employees of LMB joined the combined company in their respective roles pursuant to the acquisition.

Categories: M&A


You Might Also Like
Read Full PostRead - Eye Icon
Work Better, Not More: How to Improve Your Workflow at Home
Strategy
15/10/2020Work Better, Not More: How to Improve Your Workflow at Home

Being a remote worker can cause you to feel like you never actually have time off. You may find yourself replying to emails when you're in bed, or texting a coworker about a project while you're cooking dinner. For workaholics and perfectionists, the pressure

Read Full PostRead - Eye Icon
How to Choose the Right BI Consulting Provider
News
02/12/2022How to Choose the Right BI Consulting Provider

As the volume and variety of data soar, enterprises require more advanced analytics tools. Therefore, increasingly more organizations upscale their investments in business intelligence (BI). According to Industry Research, the global BI market will reach $35,3

Read Full PostRead - Eye Icon
Business Success: Five Ways AI Can Aid Human Connection and Collaboration
Innovation
17/04/2023Business Success: Five Ways AI Can Aid Human Connection and Collaboration

Technology is constantly changing the way we work, and automation is something business owners will be keeping an eye on in the future. This is definitely the case with artificial intelligence, with the global market for AI predicted to reach $267 billion by 2

Read Full PostRead - Eye Icon
Unlocking the Value of Our Ideas – What Really is Intellectual Property?
Legal
10/01/2024Unlocking the Value of Our Ideas – What Really is Intellectual Property?

In today’s dynamic, diverse and competitive business landscape, safeguarding your innovative ideas and creative assets is increasingly paramount. Many businesses' largest and most valuable assets include things which are not physical and instead are intangib

Read Full PostRead - Eye Icon
Care By the Sea
Leadership
09/03/2021Care By the Sea

So much more than simply a domiciliary care agency, Overington Care does not merely assist people to live an independent life in their own homes, it also has a strong focus on the mental wellbeing of its clients and its staff. Founder and owner, Nichola, tells

Read Full PostRead - Eye Icon
The people-focused business. 
Innovation
28/07/2022The people-focused business. 

Personio has focused on one of the most important aspects of business life – people.

Read Full PostRead - Eye Icon
The Global Face of Fraud: Mitigating Fraud Risks When Expanding Internationally
News
13/11/2023The Global Face of Fraud: Mitigating Fraud Risks When Expanding Internationally

Global expansion is the way forward for businesses looking to upscale in 2023 and beyond. The past few years have laid the foundation for international expansion, and now more and more merchants are embracing the opportunities.

Read Full PostRead - Eye Icon
Debt Consolidation: The Benefits, Options, and How to Get Started
News
10/06/2022Debt Consolidation: The Benefits, Options, and How to Get Started

If you’re struggling to keep up with multiple monthly payments from a list of cash advance apps, debt consolidation may be a good option for you. This process involves combining all of your outstanding debts into a single balance that has a lower interes

Read Full PostRead - Eye Icon
5 Questions To Ask Before Putting AI Into Practice And A Checklist For Success
Innovation
03/01/20205 Questions To Ask Before Putting AI Into Practice And A Checklist For Success

Despite the power of Artificial Intelligence to transform the customer experience, many AI projects fail at the first hurdle. Henry Jinman at EBI.AI outlines the 5 most common mistakes and how to avoid them using a tried and tested checklist.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow